| Revenue growth | -16% YoY for FY26; Q4FY26 -12% YoY. |
|---|---|
| Margins | FY26 EBITDA margin at 25%, meeting guidance despite top-line pressure. |
| Order book | Continues to support growth outlook for FY27. |
| Demand visibility | Strong order book; cautious optimism for H2FY27. |
| Management confidence | Positive for FY27 growth despite cyclical volatility. |
Growth
FY26 Revenue fell 16%, EBITDA dropped 22%, and PAT decreased 20%. Q4FY26 revenue saw a 12% decline YoY.
Outlook
Positive FY27 outlook with 5+ new molecules for launch; FY26 capex was ₹11,508 Mn; Pharma revenue grew 40%.
Risks
Global agrochemical industry contraction, lower crop prices, adverse weather, and elevated market inventory levels in the domestic segment.
Earnings Call filed with NSE, NSE: PIIND. Summary written with AI assistance from the document.
PI Industries Ltd: key numbers
- Share price
- ₹2,400.00
- Market cap
- ₹36,412 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 31.3×Sector 37.5×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.83%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Other Announcement
Bhavina J Dholariya, an immediate relative of an insider, sold equity shares of PI Industries Ltd. The market sale was valued at ₹0.12 Crore.
- Value
- ₹0.12 Cr
PI Industries Product Launch
PI Industries received registration for its indigenously developed insecticide, 'Pioxaniliprole' (branded 'Pioxazon'), marking a key milestone in its agricultural innovation journey.
PI Industries Earnings Call Transcript: Key Takeaways
PI Industries Q1 FY27 results show resilience amidst global agrochemical headwinds, maintaining healthy EBITDA margins at 22% despite revenue softness. Management remains optimistic about a second-half recovery driven by domestic monsoon improvement and new product scale-ups.
- Call
- Guides 5% growth
PI Industries Investor Presentation: Key Takeaways
PI Industries Q1 FY27 consolidated revenue fell 10% to ₹17,023 Mn, with EBITDA down 29% and PAT down 39% due to global agrochemical headwinds and cyclical disruptions.
PI Industries Q1 FY27 Results: Net Profit ₹244.2 Cr, Down 39.0% YoY
PI Industries Ltd reported revenue from operations of ₹1,702 Cr (-10.4% YoY) and net profit of ₹244.2 Cr (-39.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹244.2 Cr · -39.0% YoY
PI Industries Earnings Call: Key Takeaways
PI Industries delivered FY26 revenue of ₹67,137M with 25% EBITDA margins. Management transitioned to an innovator-led model with the launch of its first homegrown NCE, Pioxaniliprole.